Super Current Affairs

Science & Tech

India’s First Indigenous H5N1 Poultry Vaccine Developed in Bhopal, Launch Planned for 20 November

18 November 20263 min1 source3 questionsStory 7 of 10

Source:Dainik BhaskarDainik Bhaskar

Subject: Science and Technology (Biotechnology, Animal Health) and Indian Economy (Agriculture, Livestock)|Target exams: MPPSC, MPESB

Key points for Prelims: H5N1 avian influenza, Inactivated vaccine, ICAR-NIHSAD, Clade 2.3.2.1a, Zoonotic disease

Mains syllabus mapping

  • General Studies Paper 3: Science and Technology: indigenous development of vaccines and biotechnology; Animal health and zoonotic diseases; Agriculture: livestock and poultry sector
  • General Studies Paper 2: Health: government institutions and disease control; Indian Council of Agricultural Research and its role in research institutions

Key facts for one-day exams

  • The indigenous H5N1 vaccine was developed in Bhopal.
  • The vaccine is intended for chickens.
  • The vaccine uses inactivated H5N1 clade 2.3.2.1a.
  • The vaccine launch is planned for 20 November 2026.
  • The National Institute of High Security Animal Diseases is an Indian Council of Agricultural Research institute.

Indigenous H5N1 poultry vaccine: why in the news?

The planned launch of India’s first indigenous H5N1 poultry vaccine on 20 November 2026 marks a scientific achievement in animal health and disease control, with potential to protect the poultry sector and reduce zoonotic risks.

India’s first indigenous inactivated H5N1 avian influenza vaccine for chickens has been developed in Bhopal. The Indian Council of Agricultural Research-National Institute of High Security Animal Diseases (ICAR-NIHSAD) developed the vaccine, and its launch is planned for 20 November 2026. Union Agriculture Minister Shivraj Singh Chouhan is expected to launch the vaccine on that date. The vaccine is intended to protect poultry from bird flu and reduce economic losses for farmers.

The vaccine was developed using inactivated highly pathogenic avian influenza H5N1 clade 2.3.2.1a. All technical tests of the vaccine have been completed, officials said. Bird flu outbreaks can lead to culling of chickens, disruption of farm production and financial losses for poultry businesses. Reducing the risk of animal-to-human transmission is another intended benefit of the vaccine.

What is the vaccine and how was it developed?

The vaccine is an inactivated H5N1 avian influenza vaccine, meaning it uses a pathogen that has been inactivated so it cannot replicate, while retaining components that stimulate an immune response. It was developed using the highly pathogenic H5N1 clade 2.3.2.1a virus. The ICAR-NIHSAD in Bhopal conducted the research and development over a long period.

What are the intended benefits for poultry and public health?

The vaccine is intended to protect chickens from bird flu, which can cause culling of birds, production disruption and financial losses for poultry businesses and farmers. By controlling the disease in poultry, the vaccine may also reduce the risk of zoonotic transmission of the virus from animals to humans, though this is an intended benefit and not a demonstrated outcome of deployment.

What is the next step after the planned launch?

The planned launch on 20 November 2026 follows completion of technical tests. Effective poultry protection will depend on how vaccination is deployed alongside disease surveillance and farm biosecurity measures.

Madhya Pradesh connection

Madhya Pradesh

Matters for these Madhya Pradesh exams:MPESBMPPSC

Key terms

Avian influenza:
Avian influenza is an infectious disease caused by influenza viruses that primarily affect birds.
Inactivated vaccine:
An inactivated vaccine uses a pathogen that has been inactivated so it cannot replicate, while retaining components that stimulate an immune response.
Clade:
A clade is a group of organisms or viruses that share a common ancestor.
Zoonotic transmission:
Zoonotic transmission is the spread of an infectious agent between animals and humans.

Indigenous H5N1 poultry vaccine: why it matters for exams

Exams: MPPSC, MPESB

Syllabus: Science and Technology: Vaccines and infectious diseases; Agriculture: Animal husbandry and poultry health

Common mistake: Examiners may present the vaccine as a live H5N1 vaccine or its planned launch as completed; it is inactivated and its launch was planned for 20 November 2026.

Mains practice questions

Question 1(GS-3 | 250 words | 15 marks)

Discuss the significance of India’s indigenous H5N1 poultry vaccine developed by ICAR-NIHSAD for the poultry sector, farmers and public health. What challenges must be addressed for its effective implementation?

Answer outline

  • Introduction: Open by noting that India’s first indigenous inactivated H5N1 vaccine, developed in Bhopal and slated for launch on 20 November 2026, marks a shift from import dependence to self-reliance in animal health.
  • Body:
    • Benefits to the poultry sector: protection against bird flu, reduction in culling and production losses, and financial stability for farmers.
    • Public health dimension: reducing the risk of animal-to-human (zoonotic) transmission of avian influenza, linking One Health principles.
    • Indigenous capability: role of ICAR-NIHSAD and the completion of technical tests, showing strengthened biotechnology and vaccine research.
    • Implementation challenges: ensuring cold-chain storage and distribution to rural and small poultry farms, farmer awareness and affordability, vaccination surveillance and monitoring of circulating strains.
    • Need for coordination between agriculture and health ministries, and regulatory clearance and quality assurance for scaling up production.
  • Conclusion: A balanced way forward combines timely launch with robust distribution, farmer outreach and surveillance so that the vaccine delivers both economic and public health gains.

Question 2(GS-3 | 150 words | 10 marks)

Critically examine the role of indigenous vaccine development in strengthening India’s livestock sector and disease control preparedness.

Answer outline

  • Introduction: Frame the issue with the planned 20 November 2026 launch of an indigenous inactivated H5N1 vaccine for chickens, developed by ICAR-NIHSAD in Bhopal, as an example of domestic research capacity.
  • Body:
    • Strengths: reduced import dependence, tailored response to locally circulating strains such as clade 2.3.2.1a, and faster outbreak response.
    • Limitations: vaccine efficacy must be proven in field conditions, and vaccination alone does not replace biosecurity and culling protocols.
    • Preparedness gaps: need for sustained funding, scale-up of manufacturing and integration with disease surveillance systems.
  • Conclusion: Indigenous vaccines are a vital tool, but their impact depends on field deployment, surveillance and farmer participation within a broader One Health framework.

Stuck? Get it in one tap

Practice questions

Pick an answer, then read the explanation.

  1. Q1Hard

    Consider the following statements about India’s indigenous H5N1 poultry vaccine:

    1. 1.It was developed using an inactivated virus.
    2. 2.It is intended to protect chickens.
    3. 3.Its launch was planned for 20 November 2026.

    Which of the statements given above is/are correct?

  2. Q2Medium

    Which H5N1 clade was used to develop the indigenous poultry vaccine in Bhopal?

  3. Q3Medium

    What is the primary intended benefit of the indigenous H5N1 vaccine developed in Bhopal?

Frequently asked questions

1. Where was India’s indigenous H5N1 poultry vaccine developed?

The vaccine was developed at the Indian Council of Agricultural Research-National Institute of High Security Animal Diseases in Bhopal.

2. Which virus clade was used in the Bhopal H5N1 vaccine?

The vaccine was developed using inactivated highly pathogenic H5N1 clade 2.3.2.1a.

3. When is the indigenous H5N1 poultry vaccine planned for launch?

The launch is planned for 20 November 2026.

4. What is the indigenous H5N1 vaccine intended to protect?

The vaccine is intended to protect chickens against avian influenza.

All sources

Stories from the last 30 days on the same topic, state or exams

EnvironmentMaharashtra

H5N1 outbreak: 4.13 lakh birds culled in Maharashtra

  • Outbreak location: Navapur taluka, Nandurbar district, Maharashtra
  • Birds culled: 4,13,682 layer birds
Background GK: Avian Influenza (Bird Flu)Nodal: Department of Animal Husbandry and DairyingDon't make this mistake!
4 questions · 2 minIndian Express
InfrastructureMadhya PradeshMPPSC: Very important

₹146 crore Vande Bharat maintenance depot in Bhopal

  • Location: Nishatpura, Bhopal (Madhya Pradesh)
  • Phase 1 Completion Target: September 2027
Background GK: Vande Bharat ExpressNodal: Ministry of RailwaysDon't make this mistake!
4 questions · 2 minDainik Bhaskar
Science & TechMadhya PradeshMPPSC: Important

ICMR approves free cancer testing lab at BMHRC, Bhopal

  • Full form of ICMR: Indian Council of Medical Research
  • Full form of BMHRC: Bhopal Memorial Hospital and Research Centre
Background GK: Indian Council of Medical ResearchNodal: ICMRDon't make this mistake!
4 questions · 2 minDainik Bhaskar
Science & Tech

ICAR-IIHR opens genome editing and farmer training centres

  • Full form of ICAR: Indian Council of Agricultural Research
  • Full form of IIHR: Indian Institute of Horticultural Research
Background GK: Genome editingNodal: ICARDon't make this mistake!
3 questions · 3 minPIB
PolityMadhya PradeshMPPSC: Very important

Bhopal: ₹166 crore education tax unaccounted

  • City: Bhopal, Madhya Pradesh
  • Body responsible: Bhopal Municipal Corporation
Background GK: Education CessNodal: Bhopal Municipal CorporationDon't make this mistake!
2 questions · 2 minDainik Bhaskar
AgricultureUttar PradeshUPPSC: Important

Agrotech 2026 plans 6 workshops and 25 UP farmer awards

  • Full form of ICFA: Indian Chamber of Food and Agriculture
  • Full form of ICAR: Indian Council of Agricultural Research
Background GK: Farmer Producer OrganizationNodal: ICFADon't make this mistake!
4 questions · 3 minDainik Bhaskar